N6-cyclopropyl-PMEDAP: a novel derivative of 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) with distinct metabolic, antiproliferative, and differentiation-inducing properties

Sigrid Hatse; Lieve Naesens; De Clercq Erik; Jan Balzarini

doi:10.1016/s0006-2952(99)00091-x

RDLNetworkEkosistem

Hakkımızda SSS

Giriş yap Başla

Hakkımızda SSS Gizlilik Şartlar İletişim

N6-cyclopropyl-PMEDAP: a novel derivative of 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) with distinct metabolic, antiproliferative, and differentiation-inducing properties — Sigrid Hatse (1999) | RDL Network

Back

Home
Publications
N6-cyclopropyl-PMEDAP: a novel derivative of 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) with distinct metabolic, antiproliferative, and differentiation-inducing properties

Shared by

De Clercq Erik

KU Leuven

N6-cyclopropyl-PMEDAP: a novel derivative of 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) with distinct metabolic, antiproliferative, and differentiation-inducing properties

Article 1999 en

Authors

SH
Sigrid Hatse
LN
Lieve Naesens
De Clercq Erik
KU Leuven

Discussion(0)

No comments yet. Be the first to comment.

Publication Info

DOI: 10.1016/s0006-2952(99)00091-x
Year: 1999
Published: —
Language: en

Article Details

Volume: 58
Issue: 2
Link Of The Paper: https://doi.org/10.1016/s0006-2952(99)00091-x

Timeline

Related publications

Article1991

Single-dose administration of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) in the prophylaxis of retrovirus infection in vivo

Lieve Naesens, Jan Balzarini, De Clercq Erik

Article1993

Efficacy of oral 9‐(2‐phosphonylmethoxyethyl)‐2,6‐diaminopurine (PMEDAP) in the treatment of retrovirus and cytomegalovirus infections in mice

Lieve Naesens, Johan Neyts, Jan Balzarini, Antonı́n Holý, Ivan Rosenberg, De Clercq Erik

Article1989

9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP): A novel agent with anti-human immunodeficiency virus activity in vitro and potent anti-moloney murine sarcoma virus activity in vivo

Lieve Naesens, Jan Balzarini, Ivan Rosenberg, Antonı́n Holý, De Clercq Erik

Article1998

Potent differentiation-inducing properties of the antiretroviral agent 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in the rat choriocarcinoma (RCHO) tumor cell model

Sigrid Hatse, Lieve Naesens, De Clercq Erik, Jan Balzarini

Article1997

Potent antitumor activity of the differentiation-inducing agent 9-(2-phosphonylmethoxyethyl) adenine (PMEA) in choriocarcinoma-bearing rats

Sigrid Hatse, Bart Degrève, De Clercq Erik, Michel Vandeputte, Mark Waer, Jan Balzarini

Created:

June 19, 2026